TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,123
|
1,388
|
1,176 |
| Financial expenses |
5,660
|
3,953
|
0 |
| Earnings before taxes |
-7,335
|
-17,564
|
-14,340 |
| EBITDA |
-1,490
|
-13,416
|
-14,158 |
| Total assets |
12,737
|
11,748
|
14,558 |
| Current assets |
5,777
|
5,083
|
6,146 |
| Current liabilities |
8,611
|
6,323
|
3,139 |
| Equity capital |
4,125
|
5,425
|
11,418 |
| - share capital |
5,524
|
4,830
|
2,992 |
| Employees (average) |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
32.4%
|
46.2%
|
78.4% |
| Turnover per employee |
125
|
139
|
118 |
| Profit as a percentage of turnover |
-653.2%
|
-1265.4%
|
-1219.4% |
| Return on assets (ROA) |
-13.2%
|
-115.9%
|
-98.5% |
| Current ratio |
67.1%
|
80.4%
|
195.8% |
| Return on equity (ROE) |
-177.8%
|
-323.8%
|
-125.6% |
| Change turnover |
-290
|
129
|
271 |
| Change turnover % |
-21%
|
10%
|
30% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-10%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.